Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,821,083,699
+$209,213,549 QoQ
Shares Held
7,236,861
-2.4% QoQ
Ownership
0.410%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#32
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 7%
None 10%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. ABBV ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,821,083,699 | 7,236,861 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,611,870,150 | 7,411,238 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,891,783,410 | 8,279,502 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,062,646,535 | 8,908,381 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,762,789,331 | 9,496,764 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,972,218,672 | 9,413,033 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,664,544,685 | 9,367,162 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,828,303,211 | 9,258,169 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,516,440,735 | 8,841,189 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,496,428,601 | 8,217,620 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,242,588,510 | 8,018,252 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,162,809,008 | 7,800,946 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,041,858,060 | 7,732,933 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,207,237,629 | 7,575,062 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,204,523,770 | 7,453,275 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $999,345,105 | 7,446,130 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,172,415,446 | 7,654,841 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,203,839,072 | 7,426,063 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $996,412,120 | 7,359,026 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $789,713,465 | 7,320,974 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $826,730,178 | 7,339,579 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $792,389,220 | 7,322,022 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $716,083,985 | 6,683,005 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $570,561,873 | 6,514,007 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $600,392,692 | 6,115,224 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $280,733,331 | 3,684,648 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||